Portugal, May 15 -- Portugal based R2MC-RANGEL PRODUTOS FARMACEUTICOS has secured contract from Unidade Local De Saude Do Alto Alentejo E.P.E for Call For Proposals Under Framework Agreement(S) 2023/0304 - Group 4 Medicines: Blood; 2023/0481 - Miscellaneous Medicines; 2023/0491 - Oncological And Immunological Medicines. The value of the contract is worth 13902 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....